Puerarin + tempo-modified beta-cyclodextrin

Intervention

1 paper3 findings

  • 1 lab in 1 country
  • Funders: Key Research and Development Program of Zhejiang Province and 2 more
  • Animals1

Outcomes

3

Cellular senescence

downin mice1

1 study
  1. Puerarin + tempo-modified beta-cyclodextrin decreases cellular senescence in mice.

    “The P@TCD could mitigate the ROS accumulation, reduce DNA damage, promote cell cycle progression, and attenuate cellular senescence in the corneal epithelium”

    Animalsin DEDcorneal epithelium

    Antioxidant and anti-senescence supramolecular complexes for managing dry eye diseases

    Bioactive materials13 Jun 2026

More on Cellular senescence

Corneal epithelial defects

downin mice1

1 study
  1. Puerarin + tempo-modified beta-cyclodextrin decreases corneal epithelial defects in mice.

    “P@TCD demonstrated favorable therapeutic efficacy by reversing corneal epithelial defects”

    Animalsin DED mouse modelscorneal epithelium

    Antioxidant and anti-senescence supramolecular complexes for managing dry eye diseases

    Bioactive materials13 Jun 2026

Tear break-up time

upin mice1

1 study
  1. Puerarin + tempo-modified beta-cyclodextrin improves tear break-up time in mice (> 5.3 s vs < 2.8 s).

    “improving tear film stability with TBUT values of more than 5.3 s, compared to the DED models of less than 2.8 s”

    Animalsin DED mouse modelstear film

    Antioxidant and anti-senescence supramolecular complexes for managing dry eye diseases

    Bioactive materials13 Jun 2026

More on Tear break-up time

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 1Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 months